Study: No Link Found between Statin Use and Cognitive Decline, Dementia in Older Adults
June 22, 2021

A new analysis of the large ASPREE trial found statin use in older adults is not associated in the incidence of dementia or a decline in neurocognitive health.

FDA Awards Accelerated Approval to Aducanumab for Alzheimer Disease
June 07, 2021

The FDA approved today the first drug that targets the pathophysiolgic process responsible for Alzheimer disease and the first drug since 2003 to be approved for any Alzheimer treatment.

Obsessive Compulsive Disorder Ups Ischemic Stroke Risk in Later Life
June 01, 2021

Adults with OCD were more than 3 times as likely to have an ischemic stroke after age 40 than those without the disorder, according to a study published in Stroke.

FDA/CDC Recommend Pause on J&J Vaccine Use After Reports of Blood Clots
April 13, 2021

Reports of a rare, severe type of blood clot in 6 women in the US led the agencies to halt use of the J&J product, out of an abundance of caution.

Novel Study Finds Mild COVID-19 Associated with Prominent, Persistent Neurologic Symptoms
March 24, 2021

Brain fog topped the list of neurological symptoms in patients with long-haul COVID-19 whose illness was not severe enough to warrant hospitalization, according to a novel study.

Ditans and Gepants: Headache Specialist Discusses the Game-changing Migraine Medications
March 23, 2021

Headache specialist Peter McAllister, MD, discusses how the new migraine medications differ from existing therapies.

Study: Same Risk Factors for Stroke Found in Both Young and Older Adults
March 18, 2021

Preliminary findings being presented at the International Stroke Conference 2021 show some of the same risk factors associated with stroke in older adults also cause stroke in younger adults.

Adding Icosapent Ethyl to Statin Therapy Cuts Stroke Risk, Analysis of REDUCE-IT Trial Finds
March 17, 2021

International Stroke Conference 2021: A new analysis of the landmark REDUCE-IT trial found that adding icosapent ethyl to treatment regimens that already include statins further reduces stroke risk.

Anosmia, Other Neurologic Symptoms Seen in Half of COVID-19 Patients at ED Presentation
March 16, 2021

Study: Anosmia, myalgias, and headache were the most common extrapulmonary symptoms seen in COVID-19 patients at first presentation, say investigators.

Study: Patients with Dementia at Higher Risk for COVID-19 Infection, but Not Death
March 15, 2021

International Stroke Conference: Adults with dementia are more likely to be infected with COVID-19, but no more likely to die from it vs those without cognitive impairment.